Alterity Therapeutics Files 6-K, Incorporates by Reference
Ticker: PRNAF · Form: 6-K · Filed: Aug 4, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: procedural, registration-statement, sec-filing
Related Tickers: ATHE
TL;DR
Alterity Therapeutics (ATHE) filed a 6-K, mostly procedural, incorporating docs into S-8/F-3 filings.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on August 4, 2025, to incorporate by reference into several of its existing Registration Statements on Form S-8 and Form F-3. The filing includes Exhibit 99.1, which contains responses to ASX Query Letters.
Why It Matters
This filing is procedural, incorporating previous disclosures into ongoing registration statements, which is important for maintaining compliance for securities offerings.
Risk Assessment
Risk Level: low — The filing is a routine procedural update and does not introduce new financial or operational risks.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- ASX (company) — Australian Securities Exchange, referenced in Exhibit 99.1
- Form S-8 (document) — Registration Statement type
- Form F-3 (document) — Registration Statement type
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to incorporate by reference into existing Registration Statements on Form S-8 and Form F-3, and to submit Exhibit 99.1, which contains responses to ASX Query Letters.
Which specific Registration Statements are being updated by this filing?
This Form 6-K is incorporated by reference into Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, and 333-250076).
What is included as an exhibit in this filing?
Exhibit 99.1, titled 'Response to ASX Query Letters', is submitted with this Form 6-K.
What is the principal executive office address of Alterity Therapeutics Limited?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
Does Alterity Therapeutics Limited file annual reports under Form 20-F or Form 40-F?
Alterity Therapeutics Limited indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 4, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).